Phase III, efficacy and safety study of ertugliflozin monotherapy in people with type 2 diabetes mellitus inadequately controlled with diet and exercise alone
Steven G. Terra; Kristen Focht; Melanie Davies; Juan Frias; Giuseppe Derosa; Amanda Darekar; Gregory Golm; Jeremy Johnson; Didier Saur; Brett Lauring; Sam Dagogo‐Jack
Author Information: Pfizer
|Checking for direct PDF access through Ovid|
Abstract unavailable for this article.